(Q39962247)
Statements
Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells (English)
C Ciceroni
P Mosillo
E Mastrantoni
G Carpinelli
F Santoro
R De Maria